Literature DB >> 22990110

Breast cancer metastasis.

Olivia Jane Scully1, Boon-Huat Bay, George Yip, Yingnan Yu.   

Abstract

Breast cancer metastasis accounts for the majority of deaths from breast cancer. Detection of breast cancer metastasis at the earliest stage is important for the management and prediction of breast cancer progression. Emerging techniques using the analysis of circulating tumor cells show promising results in predicting and identifying the early stages of breast cancer metastasis in patients. Additionally, a deeper understanding of the metastatic cascade in breast cancer will be critical for developing therapeutic interventions to combat breast cancer metastasis. In this review, the current and novel methods for detection of breast cancer metastasis, as well as the mechanisms involved in metastasis and the treatment of breast cancer metastasis, are discussed.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22990110

Source DB:  PubMed          Journal:  Cancer Genomics Proteomics        ISSN: 1109-6535            Impact factor:   4.069


  120 in total

1.  Gold Nanoclusters Doped with (64)Cu for CXCR4 Positron Emission Tomography Imaging of Breast Cancer and Metastasis.

Authors:  Yongfeng Zhao; Lisa Detering; Deborah Sultan; Matthew L Cooper; Meng You; Sangho Cho; Stephanie L Meier; Hannah Luehmann; Guorong Sun; Michael Rettig; Farrokh Dehdashti; Karen L Wooley; John F DiPersio; Yongjian Liu
Journal:  ACS Nano       Date:  2016-05-18       Impact factor: 15.881

Review 2.  Nanoparticles for imaging and treatment of metastatic breast cancer.

Authors:  Qingxin Mu; Hui Wang; Miqin Zhang
Journal:  Expert Opin Drug Deliv       Date:  2016-07-19       Impact factor: 6.648

3.  Nephronectin is Decreased in Metastatic Breast Carcinoma and Related to Metastatic Organs.

Authors:  Sayra Dilmac; Nuray Erin; Necdet Demir; Gamze Tanriover
Journal:  Pathol Oncol Res       Date:  2017-08-25       Impact factor: 3.201

4.  Mucin 2 (MUC2) modulates the aggressiveness of breast cancer.

Authors:  Anna Astashchanka; Thomas M Shroka; Britta M Jacobsen
Journal:  Breast Cancer Res Treat       Date:  2018-10-13       Impact factor: 4.872

5.  EMT-related protein expression in polyploid giant cancer cells and their daughter cells with different passages after triptolide treatment.

Authors:  Xinlu Wang; Minying Zheng; Fei Fei; Chunyuan Li; Jiaxing Du; Kai Liu; Yuwei Li; Shiwu Zhang
Journal:  Med Oncol       Date:  2019-08-12       Impact factor: 3.064

6.  Upregulated tumor sirtuin 2 expression correlates with reduced TNM stage and better overall survival in surgical breast cancer patients.

Authors:  Pengfei Shi; Min Zhou; Yonggang Yang
Journal:  Ir J Med Sci       Date:  2019-08-15       Impact factor: 1.568

7.  Suppression of triple-negative breast cancer metastasis by pan-DAC inhibitor panobinostat via inhibition of ZEB family of EMT master regulators.

Authors:  Lyndsay V Rhodes; Chandra R Tate; H Chris Segar; Hope E Burks; Theresa B Phamduy; Van Hoang; Steven Elliott; Diari Gilliam; F Nell Pounder; Muralidharan Anbalagan; Douglas B Chrisey; Brian G Rowan; Matthew E Burow; Bridgette M Collins-Burow
Journal:  Breast Cancer Res Treat       Date:  2014-05-09       Impact factor: 4.872

8.  High FUT3 expression is a marker of lower overall survival of breast cancer patients.

Authors:  Jessica Catarine Frutuoso do Nascimento; Eduardo Isidoro Carneiro Beltrão; Cíntia Renata Costa Rocha
Journal:  Glycoconj J       Date:  2020-02-15       Impact factor: 2.916

9.  Metastasis-associated protein ribosomal RNA processing 1 homolog B (RRP1B) modulates metastasis through regulation of histone methylation.

Authors:  Minnkyong Lee; Amy M Dworkin; Jens Lichtenberg; Shashank J Patel; Niraj S Trivedi; Derek Gildea; David M Bodine; Nigel P S Crawford
Journal:  Mol Cancer Res       Date:  2014-08-04       Impact factor: 5.852

10.  An iTEP-salinomycin nanoparticle that specifically and effectively inhibits metastases of 4T1 orthotopic breast tumors.

Authors:  Peng Zhao; Guiquan Xia; Shuyun Dong; Zhaong-Xing Jiang; Mingnan Chen
Journal:  Biomaterials       Date:  2016-03-22       Impact factor: 12.479

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.